Business
BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" the "Company," "we" or "our") today announced its fourth quarter and full-year 2025 financial results and other key updates for the quarter.
About this update from Bausch Health Companies Inc.
[{"type":"list","items":[{"val":[{"type":"text","content":"Fourth Quarter Consolidated Revenues of $2.80 billion, up 9% on a Reported basis and up 6% on an Organic (non-GAAP)1 basis over the prior year period","length":154,"tagName":"p"}]},{"val":[{"type":"text","content":"Full-Year Consolidated Revenues of $10.27 billion, up 7% on a Reported basis and 5% on an Organic (non-GAAP)1 basis","length":120,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP Net Loss Attributable to Bausch Health of $112 million for the quarter and GAAP Net Income Attributable to Bausch Health of $157 million for the year","length":154,"tagName":"p"}]},{"val":[{"type":"text","content":"Consolidated Adjusted EBITDA Attributable to Bausch Health (non-GAAP)1 of $1.05 billion for the quarter, up 13%, and $3.54 billion for the year, up 7%","length":150,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":578,"olType":false},{"type":"text","content":"BAUSCH HEALTH EXCLUDING BAUSCH + LOMB FOURTH QUARTER AND FULL-YEAR 2025 RESULTS","length":79,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"Delivered eleventh consecutive quarter of year-over-year growth in both Revenue and Adjusted EBITDA (non-GAAP)1, exceeding 2025 guidance on all metrics","length":151,"tagName":"p"}]},{"val":[{"type":"text","content":"Completed the acquisition of Shibo's full‑service aesthetics distribution business in China on December 1, 2025","length":115,"tagName":"p"}]},{"val":[{"type":"text","content":"Executed a $1.7 billion debt exchange offer during the fourth quarter and $9.6 billion in total refinancing for the Full-Year 2025, extending near- and medium-term maturities","length":174,"tagName":"p"}]},{"val":[{"type":"text","content":"Generated $362 million in Adjusted Cash Flow from Operations (non-GAAP)1 in the fourth quarter and $1.2 billion for the Full-Year 2025","length":134,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":574,"olType":false},{"type":"text","content":"LAVAL, QC, Feb. 18, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" the "Company," "we" or "our") today announced its fourth quarter and full-year 2025 financial results and other key updates for the quarter.","length":287,"tagName":"p"},{"type":"text","content":""The fourth quart...